ArticleMedicine2019
The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report.
Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.
- Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.Chinese medical journal · 2022Pooled it
- HBV and the Microbiome-PubMed Database Literature Review.Infectious disease reports · 2026Review
- Hepatic Myelopathy as a Rare but Reversible Neurological Complication Post Transjugular Intrahepatic Portosystemic Shunt (TIPS) Insertion in Liver Cirrhosis.European journal of case reports in internal medicine · 2026Article
- Hepatic myelopathy neurological complication of chronic liver disease: two case reports.Journal of medical case reports · 2024Article
- Liver Transplantation Reverses Hepatic Myelopathy in the Decompensated Phase of Cirrhosis: Case Report and Literature Review.Journal of clinical and translational hepatology · 2024Article
- Liver transplantation and comprehensive rehabilitation in the reversal of hepatic myelopathy: a case report.Frontiers in medicine · 2024Article
- Ethanol-ProducingMicroorganisms · 2023Article
- Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report.World journal of clinical cases · 2022Article
- A Narrative Review of Gut-Muscle Axis and Sarcopenia: The Potential Role of Gut Microbiota.International journal of general medicine · 2021Review
- Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis.BMJ case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleHepatic myelopathy (HM), also known as portal-systemic myelopathy, is a rare neurological complication that occurs in patients with chronic liver disease. There is no easy and feasible treatment, liver transplantation is the only accepted therapy that may be effective for patients at early stage at present. The pathogenesis of the disease is not clear yet, and the prognosis is poor. Here we describe a reversible HM after fecal microbiota transplantation. PATIENT CONCERNS: In this report, a middle-aged female patient with hepatitis B cirrhosis, occurred HM after transjugular intrahepatic portosystemic shunt, a progressive spastic paraparesis in both legs were the main symptoms. DIAGNOSIS: The patient was diagnosed with HM.
interventionsThe patient received 3 times of fecal microbiota transplantations (FMT). OUTCOMES: The patient's muscle strength of both legs were increased at various degrees, the patient's condition improved from HM2 to HM1. LESSONS: FMT may be another effective way to treat HM. It is cheaper, more operable, and simpler than the approved treatment and worthy of further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.